Nonprescription COVID-19 Test Approved by FDA

March 8, 2021 by Daniel Mollenkamp
Nonprescription COVID-19 Test Approved by FDA
FILE - In this March 1, 2021, file photo, a patient receives a shot of the Moderna COVID-19 vaccine next to a guidelines sign at a CVS Pharmacy branch in Los Angeles. More than 27 million Americans fully vaccinated against the coronavirus will have to keep waiting for guidance from U.S. health officials for what they should and shouldn’t do. The Biden administration said Friday, March 5, it’s focused on getting the guidance right and accommodating emerging science. (AP Photo/Marcio Jose Sanchez, File)

WASHINGTON – The Food and Drug Administration issued an emergency authorization for a non-prescription, over the counter nostril test for coronavirus, the agency announced on Friday. 

It’s the first over the counter molecular test they have authorized for use without a prescription. 

It’s also the latest in test and collection kits authorized by the FDA to track the virus. The FDA has authorized 330 such items in its rush to expand the testing capability and access in the U.S.

The test, Cue COVID-19 Test for Home and Over The Counter, which utilizes a nasal swab, can be used by adults and children over the age of two, the agency explained in a written statement. It offers results through a mobile app in about twenty minutes, and its track record is good. The test was able to identify 96% of positive samples from people showing symptoms and 100% from people with no symptoms, the agency reported. 

It received an emergency use authorization from the FDA, a designation which is allowed to expand access during a crisis. The agency says it has prioritized emergency use applications that would increase access to testing or testing capabilities, such as this one.

Data from Johns Hopkins University indicates that positive tests in the U.S. have been declining since January, with an average of about 4.2% coming back positive as of March 5th. According to materials published by the World Health Organization in May, a positive test rate of less than 5% is one possible indicator that a country has the epidemic under control. The total new number of tests in the country has increased since last summer. 

Acting FDA Commissioner Janet Woodcock said that the approval of this test is part of the agency’s continued effort to provide flexibility to test developers in order to speed up the availability of tests.

“The FDA will continue to expand Americans’ access to testing to help us in the fight against this pandemic, which has claimed over half a million lives in the United States,” she said.

The company that makes the test, Cue Health, told the agency that it intends to produce more than 100,000 tests per day by summer.

A+
a-
  • COVID-19 test
  • Food and Drug Administration
  • over-the-counter
  • In The News

    Health

    Voting

    Health

    Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    Five Takeaways From the Abortion Pill Case Before US Supreme Court

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

    Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    News From The Well
    scroll top